| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 4.528 | 19.455 | 129.145 | 126.159 | 43.927 |
| Total Income - EUR | - | - | - | 0 | 0 | 4.528 | 19.459 | 129.856 | 125.182 | 45.935 |
| Total Expenses - EUR | - | - | - | 51 | 63 | 0 | 13.867 | 71.635 | 72.988 | 69.810 |
| Gross Profit/Loss - EUR | - | - | - | -51 | -63 | 4.528 | 5.593 | 58.221 | 52.194 | -23.876 |
| Net Profit/Loss - EUR | - | - | - | -51 | -63 | 4.392 | 5.009 | 56.924 | 50.946 | -24.335 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 2 | 2 | 1 |
Check the financial reports for the company - Md Pharmabest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 800 | 4.551 | 8.556 | 35.302 |
| Current Assets | - | - | - | 0 | 45 | 4.571 | 14.812 | 67.023 | 84.830 | 29.183 |
| Inventories | - | - | - | 0 | 0 | 0 | 3.718 | 6.076 | 7.246 | 7.789 |
| Receivables | - | - | - | 0 | 0 | 3.928 | 5.907 | 46.636 | 73.089 | 16.310 |
| Cash | - | - | - | 0 | 45 | 643 | 5.186 | 14.311 | 4.495 | 5.083 |
| Shareholders Funds | - | - | - | -51 | -71 | 4.322 | 9.235 | 56.972 | 75.664 | 31.086 |
| Social Capital | - | - | - | 0 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 51 | 116 | 250 | 6.377 | 14.602 | 17.722 | 33.399 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Md Pharmabest S.r.l.